A new research paper describes a stepped-care treatment to help improve the quality of life for patients with chronic uticaria.
Tara Karamlou, MD, pediatric and congenital heart surgeon, discusses the results of the Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) trial, which were recently reported in the New England of Medicine.
Lead investigator of the pivotal study of the new bioresorbable stent explains the nuanced interim results (straight from ACC.17) and what to expect next.
A major multicenter study has yielded the first evidence that peripartum cardiomyopathy shares genetic variants with dilated cardiomyopathy. A co-investigator discusses the implications.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Interim results from a major study of a leadless pacemaker show good safety and efficacy, echoing a recent trial of a similar device. Here’s how these devices may shape the future of cardiac pacing.
Neither low-dose aspirin nor low-dose clonidine protects high-risk heart patients from cardiac complications after noncardiac surgery, and aspirin increases bleeding risk.